Waid City Hospital, Zurich   Report issue

Academic/Hospital Phase 2
Founded: Zurich Switzerland (1953)

Organization Overview

First Clinical Trial
2007
NCT00944684
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Waid City Hospital, Zurich | Waid City Hospital, Zurich, Switzerland

Active Ingredients

Drugs in Phase 2 Trials (2)

ribavirin (virazole) (1 trial)

sevoflurane (ultane) (1 trial)

Drugs in Other Trials (1)

vitamin d3 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hepatitis (Phase 2)

Hepatitis A (Phase 2)

Hepatitis C (Phase 2)

Hepatitis C, Chronic (Phase 2)

Hepatitis, Chronic (Phase 2)

Shock (Phase 2)

Shock, Septic (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 3
  • # of Trial APIs: 3